Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromes (Q77859035)
Jump to navigation
Jump to search
scientific article published on 01 January 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromes |
scientific article published on 01 January 1999 |
Statements
Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromes (English)
W Verbeek
B Wörmann
P Koch
C Aul
H F Hinrichs
L Balleisen
J M Rowe
J Bennett
D Haase
C Fonatsch
A Heinecke
T Büchner
1 January 1999